Enhale-GFB 400 Rotacaps
Glycopyrrolate 25 mcg + Formoterol 12 mcg + Budesonide 400 mcg Triple Rotacaps
| Composition | Glycopyrrolate 25 mcg + Formoterol 12 mcg + Budesonide 400 mcg |
|---|---|
| Dosage Form | Rotacaps (DPI) |
| Pack Type | Blister Strip |
| Pack Size | 30 Rotacaps |
| MRP | ₹ 495 |
| Therapy | G.P. — Triple Therapy ICS + LABA + LAMA |
| Storage | Store below 30 °C in a dry place, protected from heat and direct sunlight. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Enhale-GFB 400 Rotacaps
Enhale-GFB 400 Rotacaps provide triple inhaled therapy: Glycopyrrolate 25 mcg (LAMA), Formoterol 12 mcg (LABA) and Budesonide 400 mcg (ICS). Used for severe COPD with continued exacerbations on dual therapy and severe asthma requiring all three classes.
Triple therapy is now established as superior to dual therapy in patients with frequent exacerbations and persistent symptoms — providing maximum bronchodilation plus anti-inflammatory action.
Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a premium respiratory SKU.
Indications
- Severe COPD with persistent exacerbations
- Severe asthma requiring triple therapy
- Step-up from dual ICS+LABA therapy
Mechanism of Action
Glycopyrrolate antagonises muscarinic receptors (LAMA action) for additional bronchodilation. Formoterol activates β2 receptors. Budesonide suppresses airway inflammation. Triple mechanism provides maximum therapeutic effect.
Dosage & Administration
Adults: 1 rotacap twice daily via DPI. Rinse mouth.
Side Effects
Combined effects: dry mouth (Glycopyrrolate), tremor, oral candidiasis. Urinary retention.
Contraindications & Precautions
Hypersensitivity. Narrow-angle glaucoma. Urinary retention. Severe cardiovascular disease.
Storage
Store below 30 °C in a dry place, protected from heat and direct sunlight.
Enhale-GFB 400 Rotacaps is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Enhale-GFB 400 Rotacaps used for?
Enhale-GFB 400 Rotacaps contains Glycopyrrolate 25 mcg + Formoterol 12 mcg + Budesonide 400 mcg. Used as per the indications described above.
How should Enhale-GFB 400 Rotacaps be taken?
As directed by your physician. Complete the prescribed course.
Is Enhale-GFB 400 Rotacaps available for PCD pharma franchise?
Yes, Trumac Healthcare offers Enhale-GFB 400 Rotacaps on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Enhale-GFB 400 Rotacaps be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Enhale-GFB 400 Rotacaps WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Enhale-FB 400 Rotacaps — Formoterol 6 mcg + Budesonide 400 mcg per rotacap
- Enhale-FB 400 Inhaler — Formoterol 6 mcg + Budesonide 400 mcg per actuation